2 results
Approved WMORecruiting
The objective of the study is a prospective study to evaluate which type of TE shunt prosthesis is the most cost-effective.
Approved WMOCompleted
Primary Objectives* To compare the pathologic complete response (pCR) rate of neoadjuvant nivolumab + NKTR-214 to Standard of Care (SOC, no neoadjuvant therapy) in all randomized participants* To compare the event-free survival (EFS) of neoadjuvant…